SCHEMBL10169693

SCHEMBL10169693

CCCN1CC(Oc2ccc(C(=O)c3c(-c4ccc(O)cc4)noc3-c3ccccc3C)cc2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 7/20 0.43
MAPT P10636 2/20 0.36
KDM4E B2RXH2 2/20 0.36
ATM Q13315 1/20 0.36
ESR2 Q92731 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
PKM P14618 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HSD17B10 Q99714 1/20 0.35
GRIN1 Q05586 3/20 0.35
GRIN2B Q13224 3/20 0.35
S1PR1 P21453 4/20 0.35
S1PR3 Q99500 3/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
GABRA5 P31644 1/20 0.34
ADORA2B P29275 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9956790 0.99 ESR1 (0.43) ESR1MAPTKDM4EATMESR2
SCHEMBL10169847 0.93 ESR1 (0.43) ESR1MAPTESR2SMN1; SMN2NPC1
Hydrochloric Acid SCHEMBL9957448 0.93 ESR1 (0.43) ESR1MAPTESR2SMN1; SMN2NPC1
SCHEMBL9957139 0.91 ESR1 (0.43) ESR1MAPTNPSR1GRIN1GRIN2B
SCHEMBL10169845 0.90 ESR1 (0.44) ESR1MAPTKDM4EATMSMN1; SMN2
Hydrochloric Acid SCHEMBL9956555 0.89 ESR1 (0.43) ESR1MAPTKDM4EATMSMN1; SMN2
SCHEMBL9956546 0.86 ESR1 (0.43) ESR1MAPTSMN1; SMN2NPC1NPSR1
SCHEMBL10169840 0.85 ESR1 (0.41) ESR1MAPTESR2GRIN1GRIN2B
Hydrochloric Acid SCHEMBL9956229 0.85 ESR1 (0.42) ESR1MAPTSMN1; SMN2NPC1NPSR1
Hydrochloric Acid SCHEMBL17728341 0.85 ESR1 (0.40) ESR1MAPTESR2GRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9540361-B2 N-substituted azetidine derivatives MERCK SHARP & DOHME B.V. (NL) 2017-01-10 US disclosed
US-9540361-B2 N-substituted azetidine derivatives MERCK SHARP & DOHME B.V. (NL) 2017-01-10 US disclosed
EP-2655367-B1 N-SUBSTITUTED AZETIDINE DERIVATIVES MERCK SHARP & DOHME (NL) 2016-07-06 EP disclosed
US-20160130262-A1 N-SUBSTITUTED AZETIDINE DERIVATIVES MERCK SHARP & DOHME B.V. (NL) 2016-05-12 US disclosed
US-20160130262-A1 N-SUBSTITUTED AZETIDINE DERIVATIVES MERCK SHARP & DOHME B.V. (NL) 2016-05-12 US disclosed
WO-2012084711-A1 N-SUBSTITUTED AZETIDINE DERIVATIVES MSD OSS B.V. (NL) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160130262-A1 N-SUBSTITUTED AZETIDINE DERIVATIVES ESR2, ESR1, GPER1 ESR1 2/4885MAPT 3866/4885KDM4E 306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.